| Hazard Information | Back Directory | [Uses]
Cergutuzumab is a fully human IgG1 antibody that targets CEACAM5. The isotype control for Cergutuzumab can refer to Human IgG1 kappa, Isotype Control (HY-P99001)[1]. | [References]
[1] Flisikowska T, et al. A humanized minipig model for the toxicological testing of therapeutic recombinant antibodies. Nat Biomed Eng. 2022 Nov;6(11):1248-1256. DOI:10.1038/s41551-022-00921-2 |
|
|